EUVIMEDEUVIMED entdecken
BeobachtungsstudieQuerschnittstudieOpen Access · CC BY 4.0

Serum Folate and Plasma Homocysteine According to MTHFR C677T Genotype and Folic Acid Supplementation in Japanese Women Preparing for Pregnancy: A Cross-Sectional Study

Fumitoshi Koga iD, Shogo Nakayama, Shigeki Kitagami, Masayo Matsunaga, Naoko Yokoyama, Tomoyuki Fujita

Nutrients · 29.10.2026 · 18 (21) · 3594

DOI: 10.3390/nu18213594 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Nutrients, online erschienen am 29.10.2026. Verfasst von Fumitoshi Koga und 5 weiteren Autor:innen. Beteiligte Einrichtung: Koga Fumitoshi Women's Clinic, Fukuoka 810-0001, Japan. Hauptthemen laut MEDLINE: Methylenetetrahydrofolate Reductase (NADPH2), Homocysteine, Folic Acid, Dietary Supplements. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Periconceptional folic acid supplementation reduces the risk of neural tube defects. Serum folate primarily reflects recent folate exposure, whereas plasma homocysteine may provide complementary, although non-specific, information on folate-related one-carbon metabolism. We investigated the relationships among serum folate, plasma homocysteine, methylenetetrahydrofolate reductase (MTHFR) C677T genotype, and folic acid supplementation in Japanese women preparing for pregnancy.

Methods

This cross-sectional observational study included 359 Japanese women attending a fertility clinic who underwent MTHFR C677T genotyping and measurement of serum folate and plasma homocysteine. Participants were categorized according to reported supplemental folic acid intake (none, 400 µg/day, or 800 µg/day). Serum folate and plasma homocysteine concentrations were compared across supplementation categories within each genotype. Multivariable logistic regression was used to identify factors associated with plasma homocysteine concentrations ≥ 8.62 µmol/L, which was treated as an exploratory threshold rather than an established clinical cutoff.

Results

Serum folate concentrations were significantly higher among women reporting folic acid supplementation across all three genotype groups. Plasma homocysteine concentrations differed across supplementation categories in the CT and TT genotype groups, but not in the CC genotype group. Among women with the TT genotype, the proportions with plasma homocysteine concentrations ≥ 8.62 µmol/L were 64.3% without supplementation, 25.0% with 400 µg/day, and 12.5% with 800 µg/day. In multivariable analysis, the TT genotype was associated with higher odds of plasma homocysteine ≥ 8.62 µmol/L compared with the CC genotype (adjusted OR, 2.65; 95% CI, 1.25–5.56), whereas reported supplementation with 400 µg/day and 800 µg/day was associated with lower odds compared with no supplementation (adjusted OR, 0.36; 95% CI, 0.19–0.67 and adjusted OR, 0.33; 95% CI, 0.16–0.65, respectively).

Conclusions

Serum folate and plasma homocysteine provided complementary information across MTHFR C677T genotypes in this cohort. Plasma homocysteine should be interpreted in the context of multiple nutritional and genetic determinants and should not be regarded as a specific marker of folate status alone. Combined assessment of serum folate, plasma homocysteine, and MTHFR genotype may provide additional information for preconception nutritional evaluation. Further prospective studies are needed to determine the clinical utility of this approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methylenetetrahydrofolate Reductase (NADPH2)HomocysteineFolic AcidDietary SupplementsPreconception CareHumansFemaleCross-Sectional StudiesAdultGenotypePregnancyJapanAsian PeopleNeural Tube DefectsEast Asian People

Stichwörter der Autor:innen

C677T polymorphismMTHFRfolic acidhomocysteineneural tube defectsone-carbon metabolismprecision nutritionpreconception care

Substanzen

Methylenetetrahydrofolate Reductase (NADPH2)HomocysteineFolic AcidMTHFR protein, human

Autor:innen und Institutionen

  • Koga Fumitoshi Women's Clinic, Fukuoka 810-0001, Japan.
  • Himawari Ladies Clinic Kokura, Fukuoka 802-0001, Japan.

ORCID-Profile: Fumitoshi Koga

Zitieren

APA

Koga, F., Nakayama, S., Kitagami, S., Matsunaga, M., Yokoyama, N., & Fujita, T. (2026). Serum Folate and Plasma Homocysteine According to MTHFR C677T Genotype and Folic Acid Supplementation in Japanese Women Preparing for Pregnancy: A Cross-Sectional Study. Nutrients, 18(21), 3594. https://doi.org/10.3390/nu18213594

Vancouver

Koga F, Nakayama S, Kitagami S, Matsunaga M, Yokoyama N, Fujita T. Serum Folate and Plasma Homocysteine According to MTHFR C677T Genotype and Folic Acid Supplementation in Japanese Women Preparing for Pregnancy: A Cross-Sectional Study. Nutrients. 2026;18(21):3594. doi:10.3390/nu18213594

BibTeX
@article{Koga2026,
  author = {Koga, Fumitoshi and Nakayama, Shogo and Kitagami, Shigeki and Matsunaga, Masayo and Yokoyama, Naoko and Fujita, Tomoyuki},
  title = {Serum Folate and Plasma Homocysteine According to MTHFR C677T Genotype and Folic Acid Supplementation in Japanese Women Preparing for Pregnancy: A Cross-Sectional Study},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {21},
  pages = {3594},
  doi = {10.3390/nu18213594}
}
Kostenlos starten →